Webinar information
Congenital Heart Disease: Key Considerations for Genetic Counseling
If you are having trouble viewing the webinar video, please try clearing your browser’s cookies/cache.
Congenital heart disease (CHD) is a group of complex, yet common, cardiovascular malformations which have multiple underlying etiologies. The natural history of congenital heart disease has significantly evolved as improved diagnostic capabilities and surgical interventions have led to an increase in survival rates. As such, healthcare professionals are increasingly likely to encounter these patients at various life stages, each of which will have unique counseling implications.
During this webinar, Hannah Ison MSc, CGC, Allison Schartman MS, CGC, and Benjamin Helm MS, CGC will provide an overview of the recently published Congenital Heart Disease (CHD) genetic counseling practice resource as to familiarize healthcare providers with the most current counseling considerations for this patient population.
Webinar Objectives:
- Summarize the recently published genetic counseling for congenital heart disease- practice resource for the National Society of Genetic Counselors
- Demonstrate how healthcare providers across various specialties may increasingly encounter patients with congenital heart disease
- Assess the value and limitations of current genetic testing approaches for this patient population
Interested in learning more? Explore our on-demand webinars by clicking, here.
Earning CEUs:
- The National Society of Genetic Counselors (NSGC) has authorized Blueprint Genetics to offer up to .1 CEUs or 1 Category 1 contact hour for this live webinar
- The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification
- CEU fees will be sponsored by Blueprint Genetics
The opinions expressed in this webinar are solely those of the presenter and not necessarily those of Blueprint Genetics or its affiliates. Blueprint Genetics does not guarantee the accuracy or reliability of the information provided in this presentation.
Speakers
Hannah Ison
Hannah Ison is a genetic counselor at the Stanford Center for Inherited Cardiovascular Disease. She received her Master’s in Medical and Molecular Genetics from Indiana University in 2018, and returned home to California to begin her career as a genetic counselor. In her role she spans both the adult and pediatric hospitals, and works with patients with various inherited cardiovascular conditions. However, her primary clinical focus is in the congenital heart disease and inherited dyslipidemia space. Her research interests include understanding/optimizing counseling and testing strategies for patients with congenital heart disease, as well as improving early identification and treatment of individuals with inherited cholesterol conditions.
Allison Schartman
Allison Schartman is a graduate of the Indiana University Genetic Counseling Graduate Program. She currently works as a prenatal genetic counselor at Indiana University Health Riley Maternal Fetal Medicine & Fetal Center. She sees prenatal and preconception patients in several MFM clinics through IU Health and Eskenazi Hospital. She also works with patients in the Fetal Center at Riley Children’s Health. She is a clinical supervisor for the IU Genetic Counseling Graduate Program and serves on several committees within the department of Medical and Molecular Genetics.
Benjamin Helm
Benjamin Helm is an Assistant Professor of Clinical Medical & Molecular Genetics at the Indiana University School of Medicine and also works clinically at Indiana University Health in numerous cardiovascular genetics specialty clinics. Most of his work in the last 10 years has focused on the area of cardiovascular genetics, with particular interests in arrhythmias, lipid disorders, cardiomyopathies, aortopathies, and congenital heart defects. He is currently completing his doctorate in Epidemiology (focus: genetic epidemiology) at IU Fairbanks School of Public Health and has research interests in clinical prediction modeling for genetic disorders and birth defects, genetic epidemiology, tertiary NGS analysis, and polygenic scoring methods.